During the past decade, Smilow Cancer Hospital Care Center at Saint Francis conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 105 clinical trials were completed, i.e. on average, 156.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 45 clinical trials were completed. i.e. 642.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Smilow Cancer Hospital Care Center at Saint Francis" #1 sponsor was "National Cancer Institute (NCI)" with 115 trials, followed by "SWOG Cancer Research Network" with 29 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored, "Gynecologic Oncology Group" with 12 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Smilow Cancer Hospital Care Center at Saint Francis" #1 collaborator was "National Cancer Institute (NCI)" with 77 trials as a collaborator, "NRG Oncology" with 31 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Smilow Cancer Hospital Care Center at Saint Francis" are "Recurrent Ovarian Carcinoma" (12 trials), "Fallopian Tube Transitional Cell Carcinoma" (10 trials), "Ovarian Seromucinous Carcinoma" (9 trials), "Primary Peritoneal Serous Adenocarcinoma" (9 trials) and "Recurrent Breast Carcinoma" (9 trials). Many other conditions were trialed in "Smilow Cancer Hospital Care Center at Saint Francis" in a lesser frequency.

Most popular intervention types in "Smilow Cancer Hospital Care Center at Saint Francis" are "Drug" (154 trials), "Other" (138 trials), "Biological" (87 trials), "Procedure" (47 trials) and "Radiation" (18 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (91 trials), "Quality-of-Life Assessment" (51 trials), "Paclitaxel" (31 trials), "Questionnaire Administration" (25 trials) and "Carboplatin" (23 trials). Other intervention names were less common.

The vast majority of trials in "Smilow Cancer Hospital Care Center at Saint Francis" are 134 trials for "All" genders, 53 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Smilow Cancer Hospital Care Center at Saint Francis". undefined are not yet recruiting, 25 are recruiting, 105 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Smilow Cancer Hospital Care Center at Saint Francis, 2 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Smilow Cancer Hospital Care Center at Saint Francis, 10 "Phase 1" clinical trials were conducted, 104 "Phase 2" clinical trials and 91 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".